Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 16, 2022
Should we apply a treatable traits approach to asthma care?James Melhorn, Imran Howell, Ian D Pavord
The Journal of Experimental Medicine|June 2, 2023
Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flightImran Howell, Aleksandra Howell, Ian D Pavord
ERJ Open Research|February 27, 2024
How have we measured trial outcomes of asthma attack treatment? A systematic reviewImran Howell, Aleksandra Howell, Sanjay Ramakrishnan, et al.
ERJ Open Research|July 30, 2024
Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placeboImran Howell, Daniel J Bratton, Gareth Hynes, et al.
Chest|November 15, 2025
Applying Precision Medicine to the Heterogeneity of Asthma AttacksCarlos Andres Celis-Preciado, Elsa Ben Hamou Kuijpers, Sanjay Ramakrishnan, et al.
JMIR Research Protocols|June 23, 2023
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)Imran Howell, Mahdi Mahdi, Mona Bafadhel, et al.
Thorax|February 10, 2026
Review of the British Thoracic Society Winter Meeting 26-29 November 2025Cara A Flynn, Aleksandra Ola Howell, Imran Howell, et al.
Respirology (Carlton, Vic.)|July 1, 2025
The Risk-Benefit Balance of Oral Corticosteroid Treatment for Asthma Attacks: A Discrete Choice Experiment of Patients and Healthcare Professionals in the UK and New ZealandImran Howell, Jonathan Noble, Aleksandra Howell, et al.
Thorax|December 18, 2024
Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatmentGabriel Lavoie, Imran Howell, James Melhorn, et al.
The Lancet. Respiratory Medicine|November 30, 2024
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trialSanjay Ramakrishnan, Richard E K Russell, Hafiz R Mahmood, et al.
Pageof 2